Anne M Nielsen1, Whitney A Welch1, Kara L Gavin1, Alison M Cottrell1, Payton Solk1, Emily A Torre1, Danielle Blanch-Hartigan2, Siobhan M Phillips3. 1. Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, 680 N Lakeshore Drive, Suite 1400, Chicago, IL, 60611, USA. 2. Department of Natural and Applied Sciences, Bentley University, Waltham, MA, USA. 3. Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, 680 N Lakeshore Drive, Suite 1400, Chicago, IL, 60611, USA. smphillips@northwestern.edu.
Abstract
PURPOSE: Physical activity has been shown to decline over the course of chemotherapy in breast cancer survivors; yet it may reduce treatment-related side effects and emerging evidence indicates it may improve disease outcomes. Mobile health (mHealth) interventions may be an effective, scalable strategy to increase physical activity during treatment. However, little is known about breast cancer patients' interests and preferences for these interventions. It is important to understand patients' interests and preferences prior to development of mHealth physical activity interventions to increase their relevance and efficacy. METHODS: Breast cancer survivors (n = 30) participated in a semi-structured phone interview and were asked about barriers and facilitators to physical activity during chemotherapy as well as their preferences on a range of potential mHealth intervention features. Transcribed interviews were coded and key themes were analyzed using an iterative, inductive approach. RESULTS: Five key themes were extracted from the interviews: (1) need for education about physical activity during chemotherapy; (2) treatment side effects inhibit physical activity; (3) a structured, home-based, tech-supported program with in-person elements is most feasible; (4) need for a personalized, highly tailored intervention; and (5) importance of social support from other breast cancer survivors, friends, and family. CONCLUSIONS: Breast cancer survivors are interested in mHealth physical activity interventions during chemotherapy, but preferences for intervention content and delivery varied. Future work should engage patients and survivors in intervention development and testing.
PURPOSE: Physical activity has been shown to decline over the course of chemotherapy in breast cancer survivors; yet it may reduce treatment-related side effects and emerging evidence indicates it may improve disease outcomes. Mobile health (mHealth) interventions may be an effective, scalable strategy to increase physical activity during treatment. However, little is known about breast cancerpatients' interests and preferences for these interventions. It is important to understand patients' interests and preferences prior to development of mHealth physical activity interventions to increase their relevance and efficacy. METHODS:Breast cancer survivors (n = 30) participated in a semi-structured phone interview and were asked about barriers and facilitators to physical activity during chemotherapy as well as their preferences on a range of potential mHealth intervention features. Transcribed interviews were coded and key themes were analyzed using an iterative, inductive approach. RESULTS: Five key themes were extracted from the interviews: (1) need for education about physical activity during chemotherapy; (2) treatment side effects inhibit physical activity; (3) a structured, home-based, tech-supported program with in-person elements is most feasible; (4) need for a personalized, highly tailored intervention; and (5) importance of social support from other breast cancer survivors, friends, and family. CONCLUSIONS:Breast cancer survivors are interested in mHealth physical activity interventions during chemotherapy, but preferences for intervention content and delivery varied. Future work should engagepatients and survivors in intervention development and testing.
Entities:
Keywords:
Breast cancer patients; Breast cancer survivors; Chemotherapy; Physical activity; mHealth
Authors: Catherine M Sabiston; Jennifer Brunet; Jeff K Vallance; Sarkis Meterissian Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-04-21 Impact factor: 4.254
Authors: Bonnie Spring; Christine Pellegrini; H G McFadden; Angela Fidler Pfammatter; Tammy K Stump; Juned Siddique; Abby C King; Donald Hedeker Journal: J Med Internet Res Date: 2018-06-19 Impact factor: 5.428
Authors: Emily L Mueller; Anneli R Cochrane; Courtney M Moore; Kelli B Jenkins; Nerissa S Bauer; Sarah E Wiehe Journal: J Pediatr Hematol Oncol Date: 2020-11 Impact factor: 1.170
Authors: Siobhan M Phillips; Whitney A Welch; Jason Fanning; Cesar A Santa-Maria; Kara L Gavin; Lisa A Auster-Gussman; Payton Solk; Marilyn Lu; Erin Cullather; Seema A Khan; Swati A Kulkarni; William Gradishar; Juned Siddique Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-09-29 Impact factor: 4.254
Authors: Sine Rossen; Lars Kayser; Jette Vibe-Petersen; Jesper Frank Christensen; Mathias Ried-Larsen Journal: J Med Internet Res Date: 2020-08-05 Impact factor: 5.428